Skip to main content

Psoriatic Arthritis

Psoriatic Arthritis

Featured

NPF Endorsed Features
It is hypothesized that psoriatic arthritis is too often underdiagnosed, and therefore undertreated, in dermatology. In an interview with The Dermatologist, Drs Joseph F. Merola and Alice B. Gottlieb shared their insights as dual dermatologist-rheumatologists on screening for psoriatic arthritis in the patient with psoriasis.
FDA Alerts
The FDA approved guselkumab, a selective IL-23 inhibitor, for the treatment of adult patients with active psoriatic arthritis.
NPF Endorsed Features
It is hypothesized that psoriatic arthritis is too often underdiagnosed, and therefore undertreated, in dermatology. In an interview with The Dermatologist, Drs Joseph F. Merola and Alice B. Gottlieb shared their insights as dual dermatologist-
Conferences
At the 2020 Winter Clinical Dermatology Conference, Dr Merola and Dr Gottlieb spoke about their innovative sleeve for diagnosis psoriatic arthritis in the dermatology clinic.
NPF Endorsed Features
Access restrictions to therapies among patients with rheumatoid arthritis and psoriatic arthritis can significantly impact treatment effectiveness and adherence. Natalie Boytsov, PhD, discussed the implications of these restrictions with The
Back to Top